Generated record revenue of approximately $120 million for full-year 2025, driven by PAC performance Reported Adjusted EBITDA (1) of $13 million, representing 26% improvement year-over-year Provided ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results